Structural Formula (Gly03 0007 01)
Chemical structure of glycopyrrolate, showing its molecular formula C19H28BrNO3 and molecular weight 398.33.*
Glycopyrrolate Injection, Solution
Product Images NDC 76045-206
17 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 76045-206). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Gly03 0007 02)
An instructional diagram showing the outer package and components of a prefilled syringe for Glycopyrrolate injection. Labeled parts include the plunger rod, syringe barrel with a label that should not be removed, luer lock collar also labeled not to be removed, and syringe tip cap.*
Figure 2 (Gly03 0007 03)
Illustration showing hands peeling back a protective blister packaging to access a medical syringe or injection device containing medication.*
Figure 3 (Gly03 0007 04)
Illustration showing how to open a vial by twisting off the cap, with hands holding the vial and cap, and an arrow indicating the twisting motion.*
Figure (Gly03 0007 05)
Package Label (PRINCIPAL DISPLAY)
Packaging label for Glycopyrrolate Injection, USP 0.2 mg/mL, an injectable solution designed for intramuscular or intravenous use. The carton contains 24 prefilled 1 mL single dose syringes. The label includes usage warnings and emphasizes discarding unused portions. Labeler is Fresenius Kabi USA, LLC, and the NDC is 76045-206-10.*
Package Label – Principal Display (Glycopyrrolate 1 mL Blister Pack Label)
Label for Glycopyrrolate Injection, USP 0.2 mg/mL in a 1 mL prefilled single dose syringe. The label indicates the product is preservative-free, for intramuscular or intravenous use, and includes storage instructions (20° to 25°C). It is manufactured by Fresenius Kabi USA, LLC. The label also contains placeholders for expiration date and lot number.*
Figure (Gly03 0007 08)
Label for Glycopyrrolate Injection, USP 0.2 mg/mL, a single-dose 1 mL vial intended for intramuscular or intravenous use. The label features a dosage scale with 0.5 mL and 1 mL markings, the Fresenius Kabi logo, an RFID symbol, and a barcode for identification.*
Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 1 mL Carton Panel)
Label for Glycopyrrolate Injection, USP 0.2 mg/mL, for intramuscular or intravenous use. The label indicates 24 x 1 mL prefilled single dose syringes with instructions to discard unused portion. It is marked Rx only and labeled by Fresenius Kabi USA, LLC.*
Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 1 mL Blister Pack Label)
Glycopyrrolate injection, USP 0.2 mg/mL in a 1 mL prefilled single-dose syringe for intramuscular or intravenous use. The label includes storage instructions at 20° to 25°C, a barcode, and space for expiration date and lot number. It is labeled by Fresenius Kabi USA, LLC.*
Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 1 mL Syringe Label)
Label for Glycopyrrolate Injection, USP 0.2 mg/mL by Fresenius Kabi USA, LLC. The label indicates a 1 mL single dose vial for intramuscular or intravenous use, with volume markings at 0.5 mL and 1 mL. Includes a barcode and lot/serial number information.*
Package Label (PRINCIPAL DISPLAY)
Carton packaging for Glycopyrrolate Injection USP 0.4 mg/2 mL (0.2 mg/mL) by Fresenius Kabi USA, LLC. The label states it is for intramuscular or intravenous use and contains 24 prefilled single-dose 2 mL syringes. Instructions to discard unused portions and warnings not to place the syringe on a sterile field are visible.*
Package Label – Principal Display (Glycopyrrolate 2 mL Blister Pack Label)
Label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) in a 2 mL prefilled single dose syringe. The solution is for intramuscular or intravenous use, preservative free, and labeled by Fresenius Kabi USA, LLC. The label includes storage instructions, a barcode, and placeholders for expiration date and lot number.*
Package Label – Principal Display – Glycopyrrolate 2 mL Syringe Label (Gly03 0007 14)
Glycopyrrolate 0.4 mg/2 mL (0.2 mg/mL) injection solution label for single-dose 2 mL vial. For intramuscular or intravenous use, prescription only. Label includes dosage scale and Fresenius Kabi USA, LLC branding.*
Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 2 mL Carton Panel)
Label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) prefilled single dose syringes. The product is for intramuscular or intravenous use and comes in a package of 24 syringes, each containing 2 mL. The label advises not to place the syringe on a sterile field and to discard any unused portion. Manufactured by Fresenius Kabi USA, LLC.*
Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 2 mL Blister Pack Label)
Label for Glycopyrrolate Injection, USP, 0.4 mg/2 mL (0.2 mg/mL) in a 2 mL prefilled single dose syringe. The label indicates the product is preservative free and intended for intramuscular or intravenous use. It includes storage instructions (20 to 25°C) and cautions against placing the syringe on a sterile field or reusing. The label also shows a barcode and placeholder lot and expiration information. The labeler is Fresenius Kabi USA, LLC.*
Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 2 mL Syringe Label)
Label for Glycopyrrolate Injection, USP, 0.4 mg per 2 mL (0.2 mg/mL) solution for intramuscular or intravenous use. It specifies a 2 mL single dose with dosage markings from 0.5 mL to 2 mL and displays the Fresenius Kabi USA, LLC name. The label includes a barcode and numeric code 403329.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
